Glasgow CTU

@uofgmvls.bsky.social @uofgshw.bsky.social

Endotyping-informed therapy for patients with chest pain and no obstructive coronary artery disease: a randomized trial - Nature Medicine As presented at the American Heart Association Conference 2025, patients with chest pain and without obstructive coronary artery disease benefit from treatment informed by cardiovascular magnetic reso...

🫀Breakthrough for chest pain patients with clear arteries
🆕GCTU Publication: Stress MRI-guided treatment revised diagnosis in 53% of 250 patients & dramatically improved angina symptoms vs usual care
Game-changer for a common clinical puzzle
#Cardiology #clinicaltrial
www.nature.com/articles/s41...

@uofgshw.bsky.social @uofgmvls.bsky.social

Resistance Exercise Therapy After COVID-19 Infection This randomized clinical trial assesses the effects of a personalized resistance exercise intervention on exercise capacity, health status, and psychological function among adults after COVID-19 infec...

🆕GCTU Publication: 3 months of resistance exercise significantly improved Long COVID recovery
233 ppts showed better walking distance, quality of life, mental health & grip strength vs controls.
A simple, accessible intervention that works. #LongCOVID #clinicaltrial
jamanetwork.com/journals/jam...

Glasgow CTU Enquiry Form <p><strong>Privacy Notice:</strong> The information you provide will be used confidentially and solely to respond to your enquiry and will be handled in accordance with UK data protection legislation....

We've launched an improved contact form for Glasgow Clinical Trials Unit.

If you're interested in collaborating, have questions about your research or looking for support, getting in touch is now easier than ever.

👉 Fill out our form and well be in touch wkf.ms/4q5ocRU?CTUE...
#clinicaltrials

It really was. Great engagement and some really interesting discussion took place.

Yesterday GCTU hosted the UKCRC "How to be a great CI" workshop and it was a fantastic day. The day offered wonderful insights from speakers and a great opportunity to network and create relationships to support future clinical research #ClinicalTrials
@uofgmvls.bsky.social @uofgshw.bsky.social

Reposting for anyone who missed the below - places still available - great speakers confirmed - Programme in link - should be a fun and informative day! @glasgowctu.bsky.social

Please join us soon in Glasgow for a 1-day course on “How to be a Great Chief Investigator” featuring trialists and CTU experts from around Scotland - supported by UKCRC - *Thursday 9th October* - open to all!

@uofgshw.bsky.social @uofgscmh.bsky.social @uofgmvls.bsky.social

Some of the faces behind all of the hard work done at Glasgow CTU. Today we celebrate #internationalclinicaltrialsday #teamwork #teamphoto @uofgshw.bsky.social @uofgmvls.bsky.social @ukcrc-ctu.org.uk

Glasgow CTU 2024 in Numbers

Happy International Clinical Trials Day! 🧪🔬 Celebrating the impact of @glasgowctu.bsky.social in 2024. Each number on our poster represents hard work and healthcare advanced through dedicated research. Every trial brings us one step closer. #ClinicalTrialsDay @uofgmvls.bsky.social

University of Glasgow cloisters

VACANCY - Professor/Reader in Clinical Trials & Methodology

Jointly based in the Centre for Excellence in Trials Collaboration (CETC) and Glasgow Clinical Trials Unit
@glasgowctu.bsky.social

Closes 11th May
#TeamUofG

www.jobs.gla.ac.uk/job/professo...

ESO Paper of the Month The Paper of the Month initiative is brought to you by the Council of Fellows to highlight interesting and relevant papers

🏆Exciting news! ATTEST-2 has been selected as
ESOS Paper of the Month. The study explores tenecteplase vs alteplase in acute ischaemic stroke, offering promising insights for stroke treatment. Proud of our researchers!🧠 #StrokeResearch #ClinicalTrials Read Here ⬇️
eso-stroke.org/resources/pa...

Clinical trial of HIV vaccine begins in United States and South Africa Novel vaccine includes NIH-funded technology in development since 2004.

IN THE PRESS 📰
A Phase 1 HIV Vaccine clinical trial has begun in the USA and South Africa. The trial will evaluate a novel vaccine known as VIR-1388
www.nih.gov/news-events/...